Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
S-Biomedic has 1 pending office action in Biotechnology & Pharmaceuticals. The matter is assigned to 1 distinct examiner and 1 distinct art unit, indicating concentrated examination activity. MORGAN, BAILEY MICHELLE is the busiest examiner, with 1 pending matter.
The profile supports a focused response strategy for the single outstanding biotechnology and pharmaceutical matter. No further examiner or art-unit context is recorded, so counsel can direct its analysis to one examination setting. Claim amendments should remain supported by the disclosure and should address the identified examiner’s concerns without unnecessary expansion.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MORGAN, BAILEY MICHELLE | 1 | 56.3% | +58.3% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17754427 | NOVEL SKIN CARE COMPOSITION | MORGAN, BAILEY MICHELLE | 6d |
| Art Unit | Apps |
|---|---|
| 1645 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17754427 | NOVEL SKIN CARE COMPOSITION | MORGAN, BAILEY MICHELLE | 1645 | §112Other | Final Rejection | 6d | Pending | Apr 01, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialS-Biomedic has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Bailey Michelle Morgan has the most, with 1 of S-Biomedic's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
